Andamento PODD · Insulet Corporation
Cosa dice MarketSider oggi
Chi è Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Valutazione
Redditività
Crescita
Solidità Finanziaria
Cosa ne pensano gli analisti
Approfondisci i fondamentali
Analisi tecnica AI — 03 settembre 2026
RSI (14) — Zona neutrale50▾
MACD — MACD negativo debole-0.10▾
Performance oggi — Invariato-0.16%▾
Sentiment AI notizie — Neutro0▾
Continua a imparare
Titoli correlati — Healthcare
18 in evidenza ora (selezione per movimento) · 70 nel settore
Ultime notizie su Insulet Corporation
Nessuna notizia recente su Insulet Corporation
Le notizie vengono aggiornate ogni 2 ore dalla pipeline AI.
Vai alle ultime notizieAnalisi approfondita su Insulet Corporation: target price, rischi, opportunità e confronto competitor.